Dr. Lily Vartanyan, MD

Dr. Vartanyan practices at Sharp Tri-City Medical Center in Oceanside, California, part of Sharp HealthCare.

Dr. Vartanyan's NPI, 1427547389, was assigned on May 7, 2018. Dr. Vartanyan graduated from Keck School of Medicine of USC in 2018. Dr. Vartanyan's California license number on file is A167006.

Dr. Vartanyan's primary practice is Sharp Tri-City Medical Center, at 4002 Vista Way, Oceanside, CA 92056 in San Diego County. The practice phone is (760) 724-8411.

Dr. Vartanyan's primary practice is Sharp Tri-City Medical Center in Oceanside, California, part of Sharp HealthCare. Dr. Vartanyan is also affiliated with Dignity Health - Glendale Memorial Hospital and Health Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Vartanyan to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vartanyan practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Vartanyan's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Vartanyan is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Vartanyan has a license on file in California.

CMS data shows 492 Medicare services from Dr. Vartanyan across 4 procedure codes in 2024, for 459 Medicare patients. Medicare paid $68,155 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 459 Medicare patients who saw Dr. Vartanyan in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have arthritis, and 75% have high blood pressure. 87% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vartanyan's median patient age at 51, with 54% women.

In 2024, Dr. Vartanyan wrote 200 Medicare Part D claims for 132 patients. 94% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $273 in total drug cost. In 2023, CMS named 50 claims across 4 drugs.

Dr. Vartanyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dr. Vartanyan graduated from Keck School of Medicine of USC in 2018. Dr. Vartanyan is a member of ACEP.

Dr. Vartanyan is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.